Improving symptoms of intermittent claudication in patients with erectile dysfunction and peripheral vascular disease: a pilot study assessing the benefit of daily dosing with Cialis (tadalafil) 10 mg
Not Applicable
Completed
- Conditions
- Erectile dysfunction, peripheral vascular diseaseCirculatory SystemPeripheral vascular disease
- Registration Number
- ISRCTN40898239
- Lead Sponsor
- Guy's and St Thomas' NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
1. Male aged 40 - 80 years
2. Erectile dysfunction (Sexual Health Inventory for Men [SHIM] score less than 21)
3. Peripheral vascular disease (PVD) (confirmed by previous ultrasound studies)
Exclusion Criteria
1. Contraindication to PDE 5 inhibitor
2. Inability to undertake an exercise tolerance test
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total number of minutes/seconds on the exercise treadmill. Time to first report of leg pain will be recorded, measured at the end of weeks 3, 4 and 6
- Secondary Outcome Measures
Name Time Method Change in score on the Walking Impairment Questionnaire and the Peripheral Artery Disease Symptom Scale, measured at the end of weeks 3, 4 and 6